HCAT Historical PE Ratio Notes

— Health Catalyst (NASDAQ: HCAT) is a leading provider of data analytics & technology solutions for the healthcare industry, focusing on enabling hospitals, health systems, and other healthcare organizations to improve clinical, financial, & operational outcomes. The company's platform leverages vast quantities of healthcare data — transforming raw information into actionable insights that drive efficiency and quality improvements. When considering HCAT's historical price-to-earnings (PE) ratio, it's important to note that, as a growth-focused technology company, Health Catalyst has often operated at a loss or with very slim profits. This results in atypical or even negative PE ratios for much of its public history, which is not uncommon among SaaS & analytics providers aggressively investing in R&D and sales expansion. The stock market's valuation of HCAT thus reflects expectations for future earnings potential, market share growth, & eventual profitability, sometimes assigning a relatively high or volatile PE ratio compared to established healthcare or tech firms. As you review HCAT's historical price, earnings, and PE data, consider the company's rapid growth trajectory, reinvestment strategies, and the inherent volatility that comes from prioritizing long-term gains over short-term earnings.

On this page we presented the Health Catalyst Historical PE Ratio information for Health Catalyst' stock. The average HCAT historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 42.6. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average HCAT historical PE based on this TTM earnings result method is 31.1. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this HCAT historical PE result, against the recent PE: when this page was posted on 6/12/2026, the most recent closing price for HCAT had been 1.85, and the most recent quarterly earnings result, annualized, was 0.08. Meanwhile, the most recent TTM earnings summed to 0.2. From these numbers, we calculate the recent HCAT PE on 6/12/2026 based on annualized quarterly EPS was 23.1. Based on HCAT's history, that recent PE is low relative to the historical average, with the recent PE 45.8% lower than the historical average PE across our data set for Health Catalyst. Looking at the recent HCAT PE on 6/12/2026 based on TTM EPS, we calculate the ratio at 9.2. Based on HCAT's history, that recent PE is low relative to the historical average, with the recent PE 70.4% lower than the average PE across our Health Catalyst data set with TTM EPS used in the calculation at each period.

Another interesting HCAT historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for HCAT, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for HCAT, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.02, 0.04, 0.06, and 0.08. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.04 and 0.06 — which gives us the median of 0.05. Basically the way to think about this 0.05 number is this: for the trailing four earnings reports, 0.05 marks the "middle ground" number where HCAT has reported a value higher than 0.05 half the time, and has reported a value lower than 0.05 half the time. Annualizing that median value then gets us to 0.2/share, which we use as the denominator in our next PE calculation. With 1.85 as the numerator (as of 6/12/2026), the calculation is then 1.85 / 0.2 = 9.2 as the HCAT PE ratio as of 6/12/2026, based on that annualized median value we calculated.

For self directed investors doing their due diligence on HCAT or any other given stock, valuation analysis for HCAT can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Health Catalyst PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for HCAT. Thanks for visiting, and the next time you need to research HCAT Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.